Assessing Vaccine Attitudes: A Cross-Sectional Study In Hyderabad, India

Authors

  • Sobia Noor Department of Pharmacy Practice, Anwarul Uloom College of Pharmacy, Hyderabad, Telangana, India
  • Juvariya Afroze Department of Pharmacy Practice, Anwarul Uloom College of Pharmacy, Hyderabad, Telangana, India
  • Syeda Safa Afshi Department of Pharmacy Practice, Anwarul Uloom College of Pharmacy, Hyderabad, Telangana, India
  • Mohammed Fahad Department of Pharmacy Practice, Anwarul Uloom College of Pharmacy, Hyderabad, Telangana, India
  • Shaik Shahbaaz Department of Pharmacy Practice, Anwarul Uloom College of Pharmacy, Hyderabad, Telangana, India

Abstract

This study assessed vaccine acceptance, hesitancy, and skepticism among adults aged 18 years and above in Hyderabad, India, amid the COVID-19 pandemic. Conducted from November 2020 to June 2021, the web-based observational survey gathered responses from 255 participants using a comprehensive questionnaire. The survey examined socio-demographic aspects, understanding of COVID-19 and vaccinations, perceptions of vaccine safety and effectiveness, and readiness to financially contribute to receiving the vaccine. The findings revealed that 84.71% 84.71% of the individuals were open to getting the COVID-19 vaccination, while 26.67% identified as anti-vaxxers. The majority of respondents (88.63%) concurred that vaccines are crucial in preventing severe illnesses. However, 58.43% expressed worries about potential long-term health issues arising from the vaccine. Trust in vaccine producers was mixed, with 61.96% expressing trust. Education level significantly influenced vaccine acceptance, with higher-educated individuals showing greater willingness to get vaccinated. These insights into vaccine acceptance and perceptions offer valuable guidance for policymakers and authorities responsible for public health in dealing with vaccine reluctance and improving vaccination campaigns. The findings of the study are crucial in the current context of increasing reports of adverse vaccine effects, providing valuable guidance for public health strategies to enhance vaccine uptake.

Keywords:

COVID-19, Vaccine Acceptance, Vaccine Hesitancy, Public Health, Vaccine Safety

DOI

https://doi.org/10.25004/IJPSDR.2024.160414

References

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10. PMID: 33301246; PMCID: PMC7745181.

MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015 Aug 14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036. Epub 2015 Apr 17. PMID: 25896383.

Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr. 2020 Jun;51:102083. doi: 10.1016/j.ajp.2020.102083. Epub 2020 Apr 8. PMID: 32283510; PMCID: PMC7139237.

Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020 Sep;26:100495. doi 10.1016/j.eclinm.2020.100495. Epub 2020 Aug 12. PMID: 32838242; PMCID: PMC7423333.

Kumari A, Ranjan P, Chopra S, Kaur D, Kaur T, Upadhyay AD, Isaac JA, Kasiraj R, Prakash B, Kumar P, Dwivedi SN, Vikram NK. Knowledge, barriers and facilitators regarding COVID-19 vaccine and vaccination programme among the general population: A cross-sectional survey from one thousand two hundred and forty-nine participants. Diabetes Metab Syndr. 2021 May-Jun;15(3):987-992. Doi: 10.1016/j.dsx.2021.04.015. Epub 2021 May 1. PMID: 33984818; PMCID: PMC8087578.

Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 Feb;27(2):225-228. Doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20. Erratum in: Nat Med. 2021 Jan 11;: PMID: 33082575; PMCID: PMC7573523.

Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020 Aug;35(8):775-779. doi: 10.1007/s10654-020-00671-y. Epub 2020 Aug 12. PMID: 32785815; PMCID: PMC8851308.

Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, Cravioto A, Rees H, Higgins JPT, Boutron I, Pan H, Gruber MF, Arora N, Kazi F, Gaspar R, Swaminathan S, Ryan MJ, Henao-Restrepo AM. Considerations in boosting COVID-19 vaccine immune responses. Lancet. 2021 Oct 9;398(10308):1377-1380. doi: 10.1016/S0140-6736(21)02046-8. Epub 2021 Sep 14. PMID: 34534516; PMCID: PMC8437678.

Sallam M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines (Basel). 2021 Feb 16;9(2):160. doi: 10.3390/vaccines9020160. PMID: 33669441; PMCID: PMC7920465.

Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One. 2018 Dec 7;13(12):e0208601. doi: 10.1371/journal.pone.0208601. PMID: 30532274; PMCID: PMC6285469.

Lin C, Tu P, Beitsch LM. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines (Basel). 2020 Dec 30;9(1):16. doi: 10.3390/vaccines9010016. PMID: 33396832; PMCID: PMC7823859.

Biasio LR, Bonaccorsi G, Lorini C, Pecorelli S. Assessing COVID-19 vaccine literacy: a preliminary online survey. Hum Vaccin Immunother. 2021 May 4;17(5):1304-1312. doi: 10.1080/21645515.2020.1829315. Epub 2020 Oct 29. PMID: 33118868; PMCID: PMC8078752.

Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel). 2020 Aug 27;8(3):482. doi: 10.3390/vaccines8030482. PMID: 32867224; PMCID: PMC7565574.

Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front Public Health. 2020 Jul 14;8:381. doi: 10.3389/fpubh.2020.00381. PMID: 32760691; PMCID: PMC7372105.

Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychological Medicine. 2022;52(14):3127–41. doi:10.1017/S0033291720005188

Muqattash R, Niankara I, Traoret RI. Survey data for COVID-19 vaccine preference analysis in the United Arab Emirates. Data Brief. 2020 Dec;33:106446. doi: 10.1016/j.dib.2020.106446. Epub 2020 Oct 22. PMID: 33106773; PMCID: PMC7577918.

Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD. Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). 2020 Oct 3;8(4):582. doi: 10.3390/vaccines8040582. PMID: 33022917; PMCID: PMC7711655.

Published

30-07-2024
Statistics
Abstract Display: 422
PDF Downloads: 407
Dimension Badge

How to Cite

“Assessing Vaccine Attitudes: A Cross-Sectional Study In Hyderabad, India”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 4, July 2024, pp. 655-61, https://doi.org/10.25004/IJPSDR.2024.160414.

Issue

Section

Research Article

How to Cite

“Assessing Vaccine Attitudes: A Cross-Sectional Study In Hyderabad, India”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 4, July 2024, pp. 655-61, https://doi.org/10.25004/IJPSDR.2024.160414.

Similar Articles

1-10 of 177

You may also start an advanced similarity search for this article.